Susquehanna Fundamental Investments’s Medifast MED Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39,574	Closed	-$541K	–	646
2025 Q3	$541K	Sell	39,574 -20,749	-34%	-$290K	0.02%	426
2025 Q2	$848K	Sell	60,323 -6,147	-9%	-$80.8K	0.02%	476
2025 Q1	$896K	Buy	+66,470	New	+$998K	0.01%	713
2021 Q3	–	Sell	-10,163	Closed	-$2.88M	–	1808
2021 Q2	$2.88M	Buy	+10,163	New	+$2.75M	0.05%	471

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Susquehanna Fundamental Investments's MED Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Medifast (MED) in Q4 2025, closing a stake of 39,574 shares — an estimated $541K sold.

Susquehanna Fundamental Investments first reported a position in MED in Q2 2021 and held it in 4 quarters. The position peaked at $2.88M in Q2 2021. 109 funds tracked by Wall St. Rank hold MED as of Q4 2025.

Susquehanna Fundamental Investments reported no remaining Medifast position as of Q4 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 39,574 Medifast shares in Q4 2025, an estimated $541K.
Susquehanna Fundamental Investments first reported a position in Medifast in Q2 2021 and held it in 4 quarters.
Susquehanna Fundamental Investments's Medifast position peaked at $2.88M in Q2 2021.
109 funds tracked by Wall St. Rank held Medifast as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.